Home
|
Inbox
|
Search
|
Speaker
Harrison W. Farber
MD
Boston Univ Sch of Med;Boston University School of Medicine;Pulmonary Center, Boston University School of Medicine
Session(s)
- Comparison of Three Risk Assessment Strategies as Predictors of One-Year Survival in US Pu...
Sunday, May 20 9:15 AM - 11:15 AM - Obesity Is Associated with Better Hemodynamic Measurements in Patients with Sarcoidosis As...
Sunday, May 20 11:15 AM - 1:00 PM - Riociguat in Pulmonary Arterial Hypertension (PAH): Evaluation of Abbreviated Versions of ...
Sunday, May 20 11:15 AM - 1:00 PM - The United States Pulmonary Hypertension Scientific Registry (USPHSR): Preliminary Genomic...
Sunday, May 20 11:15 AM - 1:00 PM - Morphing Physiology: A Case of Occult Systemic Sclerosis Sine Scleroderma Associated Pulmo...
Monday, May 21 11:15 AM - 1:00 PM - Riociguat in Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Evaluation of Abbrevia...
Monday, May 21 11:15 AM - 1:00 PM - Baseline and Demographic Data on the First 250 Patients from SPHERE (Uptravi® [SelexiPag]:...
Tuesday, May 22 11:15 AM - 1:00 PM - Outcomes of Patients with Pulmonary Hypertension Associated with Sarcoidosis Treated with ...
Tuesday, May 22 11:15 AM - 1:00 PM - Prevalence and Associated Mortality of an Echocardiographic Diagnosis of Pulmonary Hyperte...
Tuesday, May 22 11:15 AM - 1:00 PM - Transitions from Inhaled, Intravenous, Subcutaneous, or Oral Prostacyclins to Selexipag: I...
Tuesday, May 22 11:15 AM - 1:00 PM - A High Pressure Situation: Pulmonary Arterial Hypertension and a Large Pericardial Effusio...
Wednesday, May 23 11:15 AM - 1:00 PM - Ralinepag Plasma Levels Correlate with Improvements in Functional and Hemodynamic Paramete...
Wednesday, May 23 1:30 PM - 3:30 PM - Real-World Dosing and Titration of Selexipag in Patients with Pulmonary Arterial Hypertens...
Wednesday, May 23 1:30 PM - 3:30 PM
|
Home
|
Inbox
|
Search
|